top of page
Preliminary program


Keynote lecture


John DICK (Princess Margaret Cancer Center, University of Toronto, Canada)

Stem cells play a role in human leukemias from the beginning to the end


Inaugural plenary session


Elaine DZIERZAK (MRC Center for Inflammation Research, Univ. Edinburgh, Scotland)

Coming-of-age: Hematopoiesis in the embryo


Guest speakers


Jean-Pierre DE VILLARTAY (INSERM UMR1163, Dynamic Laboratory of the Genome and Immune System, Univ. Paris Descartes - Sorbonne Paris Cité, Institut Imagine)

Coupling DNA damage / repair: a way to ensure efficacy and control of genome stability during programmed DNA double strand breaks?


Estelle DUPREZ (CRCM, Marseille)

Epigenetic signatures: actors or witnesses of hematopoietic aging and leukemic development.


Thierry JAFFREDO (CNRS, UMR 7622, ​​UPMC, Paris)

New insights into the endothelial to hematopoietic transition generating hematopoietic stem and progenitor cells.


Fabienne MEGGETTO ( CRCT , Toulouse)

MicroRNA as predictive biomarkers for drug resistance in Anaplastic Lymphoma Kinase – positive T lymphomas


Francoise PORTEU (Gustave Roussy Institute, Villejuif)

Retrotransposons, antiviral response and HSC genomic stability


Christoph SCHEIERMANN (University of Geneva, Switzerland)

Circadian rhythms in the immune system


Franck STAAL (Leiden University Medical Center, LUMC, Netherlands)

How to become a T cell?


Maria TORIBIO (Department of Cell Biology and Immunology, Centro de Biologia Molecular Severo Ochoa. CSIC-UAM, Madrid, Spain)

Check-points in human T-cell development and leukemia



"Young recruits" session:


Ileana Antony-Debré (Inserm UMR1170, Gustave Roussy, Villejuif)

Transcription factors and AML


Thomas Bertero (CNRS, IPMC, Sophia-Antipolis)

Mechanical forces rewire tumor niche metabolism


Sandy Giuliano (IRCAN, University of the Cote d'Azur, Nice)

Mechanism of resistance to the anti-angiogenic treatment, sunitinib: inhibition of autophagy, inflammation and metabolic adaptation


Etienne Moussay (Laboratory of Experimental Cancer Research, Luxembourg Institute of Health, Luxembourg)

Interactions between leukemic cells and their microenvironment


Leïla Perié (Institut Curie, Paris)

Tracing hematopoiesis at the single cell level: lessons from cellular barcoding.


Melania Tesio (Oncology-hematology laboratory, U1151, Necker Hospital, Paris)

Stem cells in normal and malignant hematopoiesis


bottom of page